IL154268A0 - Improved solid pharmaceutical dosage formulation of hydrophobic drugs - Google Patents

Improved solid pharmaceutical dosage formulation of hydrophobic drugs

Info

Publication number
IL154268A0
IL154268A0 IL15426801A IL15426801A IL154268A0 IL 154268 A0 IL154268 A0 IL 154268A0 IL 15426801 A IL15426801 A IL 15426801A IL 15426801 A IL15426801 A IL 15426801A IL 154268 A0 IL154268 A0 IL 154268A0
Authority
IL
Israel
Prior art keywords
pharmaceutical dosage
solid pharmaceutical
dosage formulation
hydrophobic drugs
improved solid
Prior art date
Application number
IL15426801A
Original Assignee
Delsys Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delsys Pharmaceutical Corp filed Critical Delsys Pharmaceutical Corp
Publication of IL154268A0 publication Critical patent/IL154268A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL15426801A 2000-08-10 2001-08-09 Improved solid pharmaceutical dosage formulation of hydrophobic drugs IL154268A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22427500P 2000-08-10 2000-08-10
PCT/US2001/024949 WO2002013762A2 (en) 2000-08-10 2001-08-09 Improved solid pharmaceutical dosage formulation of hydrophobic drugs

Publications (1)

Publication Number Publication Date
IL154268A0 true IL154268A0 (en) 2003-09-17

Family

ID=22839969

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15426801A IL154268A0 (en) 2000-08-10 2001-08-09 Improved solid pharmaceutical dosage formulation of hydrophobic drugs

Country Status (10)

Country Link
US (1) US20020036154A1 (en)
EP (1) EP1307097A4 (en)
JP (1) JP2004505996A (en)
KR (1) KR20030024849A (en)
CN (1) CN1469707A (en)
AU (1) AU2001284772A1 (en)
CA (1) CA2417813A1 (en)
HU (1) HUP0301668A2 (en)
IL (1) IL154268A0 (en)
WO (1) WO2002013762A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114532D0 (en) * 2001-06-14 2001-08-08 Jagotec Ag Novel compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
SI21402A (en) * 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Lined particles and pharmaceutical forms
EP1699436A2 (en) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
DE102004056576A1 (en) * 2004-11-23 2006-05-24 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Rapid Card
JP5292105B2 (en) * 2007-01-11 2013-09-18 株式会社カネカ Method for producing coenzyme Q10 particles
KR20080076382A (en) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 Controlled-release preparation containing cilostazol and process for the preparation thereof
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
US11077134B1 (en) * 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
US4640322A (en) * 1985-06-19 1987-02-03 Cozzoli Machine Co. Method and apparatus for filling a receptacle with a material
JPH02180265A (en) * 1988-12-28 1990-07-13 Nippon Eranko Kk Charging device into capsule
US5046618A (en) * 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
IT1242614B (en) * 1990-12-07 1994-05-16 Macofar Spa MACHINE FOR DOSING AND INTRODUCTION OF POLERULENT PRODUCTS IN CONTAINERS.
US5343672A (en) * 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
US5972383A (en) * 1994-03-02 1999-10-26 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5811120A (en) * 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
FR2748989B1 (en) * 1996-05-22 1998-08-21 Henaux Claude MULTI-POCKET BAGING METHOD AND DEVICE AND BAGS THUS OBTAINED
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
WO1998029141A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
EP1014953B1 (en) * 1997-03-05 2012-04-25 Sugen, Inc. Formulations for hydrophobic pharmaceutical agents
EP1089721A1 (en) * 1998-06-10 2001-04-11 Delsys Pharmaceutical Corporation Pharmaceutical product and methods and apparatus for making same
EP1296666A2 (en) * 2000-07-06 2003-04-02 Delsys Pharmaceutical Corporation Improved thyroid hormone formulations

Also Published As

Publication number Publication date
EP1307097A2 (en) 2003-05-07
HUP0301668A2 (en) 2003-09-29
CA2417813A1 (en) 2002-02-21
KR20030024849A (en) 2003-03-26
WO2002013762A2 (en) 2002-02-21
CN1469707A (en) 2004-01-21
AU2001284772A1 (en) 2002-02-25
EP1307097A4 (en) 2004-01-28
JP2004505996A (en) 2004-02-26
US20020036154A1 (en) 2002-03-28
WO2002013762A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1624855A4 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
HUP0203451A3 (en) Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
PL356358A1 (en) Solid dosage form of someticone for oral administration
EP1246608A4 (en) Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
IL147777A0 (en) Pharmaceutical compositions containing low doses of cyclobenzaprine
PL368636A1 (en) Pharmaceutical dosage forms of epothilones for oral administration
IL162293A0 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
HUP0201450A3 (en) Solid-state form of celecoxib having enhanced bioavailability, pharmaceutical compositions containing it and their preparation
IL147826A0 (en) Multi-component pharmaceutical dosage form
GB0117618D0 (en) Pharmaceutical dosage form
EP1483277A4 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
IL154012A0 (en) Hydrogel-driven drug dosage form
AU2003215245A8 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AU2001280764A1 (en) Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
GB0117619D0 (en) Pharmaceutical dosage form
IL154268A0 (en) Improved solid pharmaceutical dosage formulation of hydrophobic drugs
EP1221926A4 (en) Pharmaceutical formulations containing poorly soluble drug substances
AU2001260089A1 (en) Pharmaceutical compositions comprising desglymidodrine as an active drug substance
HUP0303089A3 (en) Stable pharmaceutical form of an anticancer drug
HUP0200336A3 (en) Pharmaceutical effervescent formulation containing metamizol
IL155855A0 (en) Pharmaceutical formulation of gepirone for oral administration